Activity of MDI-301, a novel synthetic retinoid, in xenografts.

Appleyard, Virginia C L

Activity of MDI-301, a novel synthetic retinoid, in xenografts. [electronic resource] - Anti-cancer drugs Nov 2004 - 991-6 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

0959-4973

10.1097/00001813-200411000-00009 doi


Alitretinoin
Animals
Antineoplastic Agents--pharmacology
Breast Neoplasms
Cell Line, Tumor
Female
Humans
Immunohistochemistry
Male
Mice
Mice, Nude
Prostatic Neoplasms
Receptors, Retinoic Acid--biosynthesis
Retinoic Acid Receptor alpha
Retinoids--pharmacology
Tretinoin--pharmacology
Xenograft Model Antitumor Assays